GSC
NXTM

Ground Swell Capital’s NxStage Medical Inc. NXTM Stock Holding History

Ground Swell Capital’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$49K Buy
+3,720
New +$50.1K 0.09% 225

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BA
Broadview Advisors Milwaukee, Wisconsin $324M AUM 0.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ground Swell Capital's NXTM Position: Q3 2014 in Review

Ground Swell Capital opened a new position in NxStage Medical Inc. (NXTM) in Q3 2014: 3,720 shares worth $49K. The stake represents 0.09% of the portfolio and ranks #225 among its holdings.

111 funds tracked by Wall St. Rank hold NXTM as of Q3 2014.

  • Ground Swell Capital held 3,720 shares of NxStage Medical Inc. worth $49K as of Q3 2014.
  • NxStage Medical Inc. was a new Ground Swell Capital position in Q3 2014.
  • NxStage Medical Inc. made up 0.09% of Ground Swell Capital's portfolio in Q3 2014, its #225 holding.
  • 111 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.